All posts by: Michael Zand

About Michael Zand

Opportunities in Human Embryonic Stem Cell Products – San Francisco Chronicle (press release)

Opportunities in Human Embryonic Stem Cell ProductsSan Francisco Chronicle (press release)Human embryonic stem cells were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the …New stem cell discovery 'could … Continue reading

2013-08-15 NEWS

“Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for … – BioNews Texas

“Grafix® Demonstrates Overwhelming Efficacy in Landmark Stem Cell Study for …BioNews TexasThe University of Texas, Southwestern Medical Center has recently taken part in a successful multicentre study to assess the efficacy of the novel stem cell therapy, Grafix® produced by Osiris, for the treatment of diabetic foot ulcers. With foot … …read more   &nbs… Continue reading

2013-08-15 NEWS

Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum … – Marketwire (press release)

Third Annual Stem Cell Meeting on the Mesa Regen Med Partnering Forum …Marketwire (press release)WASHINGTON, DC–(Marketwired – Aug 15, 2013) – The Alliance for Regenerative Medicine (ARM), the international organization representing the interests of the regenerative medicine community, today announced the presenting companies for its upcoming … …read more   &nbs… Continue reading

2013-08-15 NEWS

Opportunities in Human Embryonic Stem Cell Products – Watch List News (press release)

Opportunities in Human Embryonic Stem Cell ProductsWatch List News (press release)Human embryonic stem cells were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the …and more …read more   &nbs… Continue reading

2013-08-15 NEWS